Artificial intelligence in psoriasis: Where we are and where we are going

被引:7
|
作者
Liu, Zhenhua [1 ,2 ]
Wang, Xinyu [3 ]
Ma, Yao [4 ]
Lin, Yiting [2 ]
Wang, Gang [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China
[3] Valdosta State Univ, Dept Econ Finance & Healthcare Adm, Valdosta, GA 31602 USA
[4] Fourth Mil Med Univ, Student Brigade Basic Med Sch, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
artificial intelligence; deep learning; dermatology; machine learning; psoriasis; CONVOLUTIONAL NEURAL-NETWORKS; RISK STRATIFICATION; SEVERITY INDEX; MACHINE VISION; SKIN-CANCER; SEGMENTATION; CLASSIFICATION; MANAGEMENT; ARTHRITIS; IMAGES;
D O I
10.1111/exd.14938
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Artificial intelligence (AI) is a field of computer science that involves the development of programs designed to replicate human cognitive processes and the analysis of complex data. In dermatology, which is predominantly a visual-based diagnostic field, AI has become increasingly important in improving professional processes, particularly in the diagnosis of psoriasis. In this review, we summarized current AI applications in psoriasis: (i) diagnosis, including identification, classification, lesion segmentation, lesion severity and area scoring; (ii) treatment, including prediction treatment efficiency and prediction candidate drugs; (iii) management, including e-health and preventive medicine. Key challenges and future aspects of AI in psoriasis were also discussed, in hope of providing potential directions for future studies.
引用
收藏
页码:1884 / 1899
页数:16
相关论文
共 50 条
  • [21] Artificial intelligence and inflammatory bowel disease: Where are we going?
    Leonardo Da Rio
    Marco Spadaccini
    Tommaso Lorenzo Parigi
    Roberto Gabbiadini
    Arianna Dal Buono
    Anita Busacca
    Roberta Maselli
    Alessandro Fugazza
    Matteo Colombo
    Silvia Carrara
    Gianluca Franchellucci
    Ludovico Alfarone
    Antonio Facciorusso
    Cesare Hassan
    Alessandro Repici
    Alessandro Armuzzi
    World Journal of Gastroenterology, 2023, 29 (03) : 508 - 520
  • [22] Artificial intelligence and inflammatory bowel disease: Where are we going?
    Da Rio, Leonardo
    Spadaccini, Marco
    Parigi, Tommaso Lorenzo
    Gabbiadini, Roberto
    Dal Buono, Arianna
    Busacca, Anita
    Maselli, Roberta
    Fugazza, Alessandro
    Colombo, Matteo
    Carrara, Silvia
    Franchellucci, Gianluca
    Alfarone, Ludovico
    Facciorusso, Antonio
    Hassan, Cesare
    Repici, Alessandro
    Armuzzi, Alessandro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (03) : 508 - 520
  • [23] Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?
    Bernardi, Simona
    Vallati, Mauro
    Gatta, Roberto
    CANCERS, 2024, 16 (05)
  • [24] Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?
    Ahmed M.
    Stone M.L.
    Stidham R.W.
    Current Gastroenterology Reports, 2024, 26 (5) : 137 - 144
  • [25] Where we come from, where we are, where we are going
    Leonhard, Joachim-Felix
    INFORMATION-WISSENSCHAFT UND PRAXIS, 2023, 74 (5-6): : 271 - 274
  • [26] Vitamin D analogs in the treatment of psoriasis Where are we standing and where will we be going?
    Tremezaygues, Lea
    Reichrath, Joerg
    DERMATO-ENDOCRINOLOGY, 2011, 3 (03) : 180 - 186
  • [27] The core: Where are we and where are we going?
    Sherry, M
    Best, T
    Heiderscheit, B
    CLINICAL JOURNAL OF SPORT MEDICINE, 2005, 15 (01): : 1 - 2
  • [28] VSP - WHERE WE ARE, WHERE WE ARE GOING
    HARDAGE, BA
    OIL & GAS JOURNAL, 1988, 86 (12) : 91 - 93
  • [29] AIDS - WHERE ARE WE AND WHERE ARE WE GOING
    GATELL, JM
    MEDICINA CLINICA, 1992, 98 (20): : 775 - 777
  • [30] WHERE ARE WE NOW AND WHERE ARE WE GOING
    KARLAN, BY
    GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 315 - 317